RECRUITING

Peripheral Blood Flow Responses to Electromagnetic Energy

Talk to us

Conditions

Exposure to Man-made Visible Light

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study evaluates 670 nm energy in the form of red light to stimulate blood flow changes in healthy adults. All participants will receive red light to their leg. They will also receive a continuous infusion of Definity (octafluoropropane) ultrasound contrast.

Official Title

Peripheral Blood Flow Responses to Electromagnetic Energy

Quick Facts

Study Start:2014-11
Study Completion:2025-05-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT02370199

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 59 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT
Inclusion CriteriaExclusion Criteria
  1. * Participants will be healthy subjects over the age of 18.
  2. * Men and women will be recruited for participation.
  3. * All ethnicities will be included in this study.
  1. * age under 18 years and those over 60 years of age,
  2. * those who are unable to understand the consent process,
  3. * those who cannot read or speak English,
  4. * a history of cancer,
  5. * peripheral artery disease,
  6. * diabetes mellitus,
  7. * active pregnancy,
  8. * hypersensitivity to perflutren contrast agents,
  9. * pulmonary hypertension,
  10. * chronic kidney disease,
  11. * active tobacco or drug use,
  12. * blood pressure over 160/90, BMI\>30,
  13. * sickle cell disease, or
  14. * history of intracardiac shunt.
  15. * a history of coronary artery disease,
  16. * heart failure,
  17. * the presence of an implanted defibrillator or pacemaker,
  18. * a history of heart murmur or rhythm disorder (atrial fibrillation, atrial tachycardia, or ventricular tachycardia),
  19. * neurological diseases such as stroke, and
  20. * any uncontrolled medical conditions.

Contacts and Locations

Study Contact

Nicole L Lohr, MD, PhD
CONTACT
205-996-3504
nlohr@uabmc.edu

Principal Investigator

Nicole L Lohr, MD, PhD
PRINCIPAL_INVESTIGATOR
Medical College of Wisconsin

Study Locations (Sites)

Medical College of Wisconsin
Milwaukee, Wisconsin, 53226
United States

Collaborators and Investigators

Sponsor: University of Alabama at Birmingham

  • Nicole L Lohr, MD, PhD, PRINCIPAL_INVESTIGATOR, Medical College of Wisconsin

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2014-11
Study Completion Date2025-05-01

Study Record Updates

Study Start Date2014-11
Study Completion Date2025-05-01

Terms related to this study

Additional Relevant MeSH Terms

  • Exposure to Man-made Visible Light